DPP-1 Blocker a Bust in Severe COVID

(MedPage Today) -- BARCELONA--Treatment with an investigational dipeptidyl peptidase-1 (DPP-1) inhibitor failed to improve outcomes in severe COVID-19 and was associated with worsening clinical status and greater mortality, a randomized trial...